{"ParsedSentences":["(X (X 875623313) (X |) (X HH) (X |) (X 59937331) (X |) (X |) (X 0423738) (X |) (X 7/24/2007) (X 12:00:00) (X AM) (X |) (X Asthmatic) (X flare) (X |) (X |) (X DIS) (X |) (X Admission) (X Date) (X :) (X 11/22/2007) (X Report) (X Status) (X :) (X Discharge) (X Date) (X :) (X 9/25/2007) (X ******) (X FINAL) (X DISCHARGE) (X ORDERS) (X ******) (X BELIEU) (X ,) (X BLAINE) (X 878-10-93-3Sant) (X Po) (X LualerockService) (X :) (X MEDDISCHARGE) (X PATIENT) (X ON) (X :) (X 3/26/07) (X AT) (X 04:00) (X PMCONTINGENT) (X UPON) (X Not) (X ApplicableWILL) (X D/C) (X ORDER) (X BE) (X USED) (X AS) (X THE) (X D/C) (X SUMMARY) (X :) (X YESAttending) (X :) (X JANNELL) (X ,) (X BRYON) (X A.) (X ,) (X M.D.CODE) (X STATUS) (X :) (X Full) (X codeDISPOSITION) (X :) (X Home) (X w) (X /) (X servicesMEDICATIONS) (X ON) (X ADMISSION) (X :1) (X .))","(ROOT (NP (NP (NNP AMLODIPINE) (CD 10)) (NP (NNP MG) (NNP PO) (NNP QD2)) (. .)))","(ROOT (NP (NNP GABAPENTIN) (NNP 300) (NNP MG) (NNP PO) (NNP TID3) (. .)))","(ROOT (NP (NP (NNP HYDROCHLOROTHIAZIDE) (CD 25)) (NP (NNP MG) (NNP PO) (NNP QD4)) (. .)))","(ROOT (NP (NNP PHENYTOIN) (NNP 250) (NNP MG) (NNP PO) (NNP BID5) (. .)))","(ROOT (NP (NNP SIMVASTATIN) (NNP 20) (NNP MG) (NNP PO) (NNP QHS6) (. .)))","(ROOT (NP (NP (NNP LISINOPRIL) (CD 40)) (NP (NNP MG) (NNP PO) (NNP QD7)) (. .)))","(ROOT (NP (NP (NNP ALBUTEROL) (NNP INHALER)) (NP (NP (CD 2)) (NP (NNP PUFF) (NNP INH) (NNP Q4H8))) (. .)))","(ROOT (S (NP (NNP FLUTICASONE) (NNP PROPIONATE) (NNP 110) (NNP MCG) (NNP ORAL) (NNP INHALER) (CD 2)) (VP (VBZ PUFFS) (NP (NNP INH) (NNP BID9))) (. .)))","(X (X CITALOPRAM) (X 20) (X MG) (X PO) (X QDMEDICATIONS) (X ON) (X DISCHARGE) (X :) (X ALBUTEROL) (X INHALER) (X 2) (X PUFF) (X INH) (X Q4H) (X PRN) (X WheezingNORVASC) (X -LRB-) (X AMLODIPINE) (X -RRB-) (X 10) (X MG) (X PO) (X DAILY) (X HOLD) (X IF) (X :) (X SBP) (X \u003c) (X 90Food/Drug) (X Interaction) (X InstructionAvoid) (X grapefruit) (X unless) (X MD) (X instructs) (X otherwise.CIPROFLOXACIN) (X 250) (X MG) (X PO) (X Q12H) (X X) (X 3) (X dosesStarting) (X Today) (X -LRB-) (X 3/10) (X -RRB-) (X Food/Drug) (X Interaction) (X InstructionAdminister) (X iron) (X products) (X a) (X minimum) (X of) (X 2) (X hours) (X before) (X orafter) (X a) (X levofloxacin) (X or) (X ciprofloxacin) (X dose) (X doseIf) (X on) (X tube) (X feeds) (X ,) (X please) (X cycle) (X -LRB-) (X hold) (X 1) (X hr) (X before) (X to) (X 2) (X hrafter) (X -RRB-) (X Take) (X 2) (X hours) (X before) (X or) (X 2) (X hours) (X after) (X dairy) (X products.CITALOPRAM) (X 20) (X MG) (X PO) (X DAILYFLOVENT) (X HFA) (X -LRB-) (X FLUTICASONE) (X PROPIONATE) (X INH) (X -RRB-) (X 110) (X MCG) (X INH) (X BID) (X Instructions) (X :) (X 2) (X puffs) (X twice) (X dailyNEURONTIN) (X -LRB-) (X GABAPENTIN) (X -RRB-) (X 600) (X MG) (X PO) (X TIDHYDROCHLOROTHIAZIDE) (X 25) (X MG) (X PO) (X DAILY) (X HOLD) (X IF) (X :) (X SBP) (X \u003c) (X 90LISINOPRIL) (X 40) (X MG) (X PO) (X DAILY) (X HOLD) (X IF) (X :) (X SBP) (X \u003c) (X 90DILANTIN) (X -LRB-) (X PHENYTOIN) (X -RRB-) (X 230) (X MG) (X QAM) (X ;) (X 200) (X MG) (X QPM) (X PO230) (X MG) (X QAM) (X 200) (X MG) (X QPM) (X Food/Drug) (X Interaction) (X InstructionIf) (X on) (X tube) (X feeds) (X ,) (X please) (X cycle) (X -LRB-) (X hold) (X 1) (X hr) (X before) (X to) (X 2) (X hrafter) (X -RRB-) (X ZOCOR) (X -LRB-) (X SIMVASTATIN) (X -RRB-) (X 20) (X MG) (X PO) (X BEDTIMEFood/Drug) (X Interaction) (X InstructionAvoid) (X grapefruit) (X unless) (X MD) (X instructs) (X otherwise.REPLIVA) (X 9/30) (X TABLET) (X 15-200-1) (X 1) (X TAB) (X PO) (X DAILYDIET) (X :) (X House) (X /) (X Low) (X chol/low) (X sat) (X .))","(X (X fatACTIVITY) (X :) (X Resume) (X regular) (X exerciseFOLLOW) (X UP) (X APPOINTMENT) (X -LRB-) (X S) (X -RRB-) (X :) (X Dr.) (X Frey) (X -LRB-) (X neurologist) (X -RRB-) (X please) (X call) (X to) (X set) (X up) (X within) (X next) (X 1-2) (X weeks) (X ,) (X Dr.) (X Kohli) (X -RRB-) (X outpt) (X pulmonologist) (X -RRB-) (X Thursday) (X October) (X ,) (X 2007) (X at) (X 1:40) (X PM) (X scheduled) (X ,) (X Dr.) (X Stonewall) (X -LRB-) (X primary) (X care) (X physician) (X -RRB-) (X June) (X ,) (X 2007) (X scheduled) (X ,) (X ALLERGY) (X :) (X NKAADMIT) (X DIAGNOSIS) (X :) (X HypoxemiaPRINCIPAL) (X DISCHARGE) (X DIAGNOSIS) (X ;) (X Responsible) (X After) (X Study) (X for) (X Causing) (X Admission) (X -RRB-) (X Asthmatic) (X flareOTHER) (X DIAGNOSIS) (X ;) (X Conditions) (X ,) (X Infections) (X ,) (X Complications) (X ,) (X affecting) (X Treatment/StayAcute) (X Asthma) (X FlareOPERATIONS) (X AND) (X PROCEDURES) (X :) (X OTHER) (X TREATMENTS/PROCEDURES) (X -LRB-) (X NOT) (X IN) (X O.R.) (X -RRB-) (X Echocardiogram) (X 9/25/07BRIEF) (X RESUME) (X OF) (X HOSPITAL) (X COURSE) (X :) (X CC) (X :) (X seizures) (X ,) (X hypoxemiaHPI) (X :) (X 53F) (X h/o) (X sarcoid) (X ,) (X seizure) (X disorder) (X within) (X the) (X last) (X year) (X ,) (X possiblecardiomyopathy) (X ,) (X asthma) (X ,) (X smoking) (X ,) (X HTN) (X ,) (X and) (X obesity) (X p/w) (X seizure) (X activityat) (X home) (X and) (X then) (X later) (X in) (X the) (X ED) (X .))","(ROOT (SQ (VBZ Has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (NN intermittentnon-adherence)) (PP (TO to) (NP (JJ prescribed) (NN dilantin)))))) (VP (VBN regimen)) (. .)))","(ROOT (NP (NP (JJ Treated) (NN acutely) (NN withativan)) (, ,) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (JJ subtherapeutic) (PP (IN on) (NP (NN dilantin)))) (SBAR (IN so) (S (NP (JJ re-loaded) (NN withdilantin)) (VP (TO to) (VP (VB achieve) (NP (JJ therapeutic) (NNS levels)))))))))) (. .)))","(ROOT (S (NP (NP (NNP Observed)) (PP (IN in) (NP (NNP ED)))) (VP (VP (ADVP (RB overnight)) (VBZ withplans) (PP (IN for) (NP (NN morning) (NN discharge)))) (, ,) (CC but) (VP (VBD became) (ADJP (ADJP (ADJP (RB questionably) (JJ hypoxemic)) (PRN (-LRB- -LRB-) (NP (NN O2) (NN satlow) (NNS 90s)) (-RRB- -RRB-))) (CC and) (ADJP (RB somewhat) (RB subjectively) (JJ dyspneic))))) (. .)))","(ROOT (S (NP (NP (DT The) (NNS physicians)) (PP (IN in) (NP (JJ theemergency) (NN room)))) (VP (VP (VBD thought) (SBAR (IN that) (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN havingan) (NP (NN asthma) (NN exacerbation))))))) (CC and) (VP (VBD gave) (NP (DT the) (ADJP (JJ patient) (JJ prednisone)) (JJ 60mg) (NN x)) (NP (CD 1)) (, ,) (NP (NP (JJ combivent/albuterol) (NN nebulizer) (NN treatment)) (, ,) (NP (JJ levofloxacin/clindamycinfor) (JJ possible) (NN aspiration) (NN pneumonia)))) (, ,) (CC and) (VP (VBD admitted) (NP (PRP her)) (PP (TO to) (NP (NP (DT the) (JJ medical) (JJ floorfor) (JJ further) (NN evaluation)) (CC and) (NP (JJ treatment.Hospital) (NNP Course) (NNP :1) (-RRB- -RRB-) (NNP Pulmonary)))))) (. .)))","(ROOT (S (PP (IN On) (NP (NP (NN admission)) (PP (TO to) (NP (DT the) (NN floor))))) (, ,) (NP (DT the) (NN patient)) (VP (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB havenormal) (NP (NN oxygen) (NNS saturations)) (PP (IN in) (NP (NP (DT the) (JJ mid) (NN 90s)) (PP (IN on) (NP (NN room) (NN air)))))))))) (CC and) (VP (VBD was) (RB not) (VP (VBN thought) (S (VP (VB tohave) (NP (NP (DT any) (JJ concurrent) (NN bronchospasm)) (CC or) (NP (NP (JJ focal) (NNS sounds)) (PP (IN of) (NP (DT a) (NN pneumonia)))))))))) (. .)))","(ROOT (S (S (NP (PRP$ Her) (NN chestx) (NN ray)) (VP (VBD was) (ADJP (JJ negative)))) (, ,) (NP (PRP she)) (VP (VBD was) (RB not) (VP (VBG having) (NP (NP (NNS fevers)) (CC and) (NP (PRP$ her) (JJ white) (NN blood) (NN count) (NN wasnormal))))) (. .)))","(ROOT (S (S (NP (PRP$ Her) (NNS steroids) (CC and) (NNS levofloxacin/clindamycin)) (VP (VBD were) (VP (VBN thereforediscontinued)))) (CC and) (S (NP (PRP she)) (VP (VBD received) (NP (PRP$ her) (NN home) (NNS inhalers) (CC and) (NNS nebulizers)) (ADVP (RB only)))) (. .)))","(ROOT (S (NP (NP (JJ Sheremained) (NN stable)) (PP (IN on) (NP (NP (DT this) (NN regimen)) (PP (IN throughout) (NP (PRP$ her) (NN hospital)))))) (VP (VBP stay)) (. .)))","(ROOT (S (S (S (NP (PRP$ Her) (NN breathsounds) (CC and) (NN heart) (NNS sounds)) (VP (VBD were) (ADVP (RB admittedly)) (ADJP (NP (DT a) (RB bit)) (JJ distant)))) (CC and) (S (NP (PRP she)) (VP (MD may) (VP (VB have) (NP (NP (NN anelement)) (PP (IN of) (NP (JJ undiagnosed) (NNP COPD)))))))) (, ,) (IN so) (S (NP (JJ pulmonary) (NN function) (NNS tests)) (VP (VBD were) (ADVP (RB recommendedas)) (NP (DT an) (NN outpatient)))) (. .)))","(ROOT (S (ADVP (RB Additionally)) (, ,) (NP (DT the) (NN patient)) (VP (MD may) (VP (VB benefit) (PP (IN from) (PRN (S (NP (DT a) (NN sleep)) (VP (VBZ studyas) (NP (NP (DT an) (NN outpatient)) (VP (VBN given) (NP (NP (PRP$ her) (NN component)) (PP (IN of) (NP (NN desaturation)))) (PP (IN while) (NP (JJ asymptomatic) (NN andsleeping))) (PP (IN during) (NP (NP (DT the) (NN night)) (PP (IN of) (NP (NN admission) (CD .2))))))))) (-RRB- -RRB-)) (NP (JJ Infectious) (NN disease))))) (. .)))","(ROOT (S (NP (DT The) (NN patient)) (VP (VBD did) (SBAR (SBAR (S (VP (VBP have) (NP (DT an) (JJ apparent) (NN urinary) (NN tractinfection))))) (CC and) (SBAR (IN so) (S (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NN ciprofloxacin) (NNS 250mg))) (ADVP (RB twice) (JJ daily) (PP (IN for) (NP (JJ threedays) (CD .3) (-RRB- -RRB-) (NNS Cardiovascular)))))))))) (. .)))","(ROOT (S (NP (DT The) (NN pt)) (VP (VBD did) (VP (VB report) (NP (NP (DT some) (NNS symptoms)) (PP (IN of) (NP (NNP PND) (CC and) (NNP orthopnea))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (ADJP (JJ stable) (PP (IN for) (NP (DT the) (JJ last) (JJ several) (NNS years))))))))))))) (. .)))","(ROOT (S (NP (PRP She)) (VP (VBD was) (RB not) (VP (VBN volumeoverloaded) (PP (IN on) (NP (NN exam))))) (. .)))","(ROOT (S (S (NP (PRP She)) (VP (VBD received) (NP (DT an) (NN echocardiogram) (S (VP (TO to) (VP (VB investigate) (NP (JJ possiblecardiomyopathy) (CC or) (JJ congestive) (NN failure)))))))) (, ,) (CC and) (S (NP (DT this)) (VP (VBD showed) (NP (DT a) (JJ normal) (NN ejectionfraction)) (PP (IN without) (NP (JJ obvious) (JJ structural) (NNS abnormalities))) (PP (IN except) (PP (IN for) (NP (JJ mild) (JJ bilateralatrial) (NN dilatation) (NNP .4) (-RRB- -RRB-) (NNP Neurological)))))) (. .)))","(ROOT (S (NP (NP (DT The) (JJ inpatient) (JJ medical) (NN team)) (VP (VBN communicated) (PP (IN with) (NP (DT the) (JJ ptsoutpatient) (NN neurologist))) (S (VP (TO to) (VP (VB discuss) (NP (NP (VBN continued) (NNS seizures)) (PP (IN in) (NP (DT the) (NN context))))))))) (VP (VBP ofquestionable) (NP (JJ intermittent) (NN noncompliance))) (. .)))","(ROOT (S (S (VP (VBG Per) (NP (NP (DT the) (NNS instructions)) (PP (IN of) (NP (NN herneurologist)))))) (, ,) (NP (DT the) (NN pts) (NN dilantin)) (VP (VBD was) (VP (VBN increased) (PP (TO to) (NP (JJ 230mg) (NNP PO) (NNP QAM) (CC and) (NNP 200mg) (NNP POQPM))) (PP (IN with) (NP (NNS plans))) (S (VP (TO to) (VP (VB check) (NP (DT another) (NN dilantin) (NN level)) (PP (IN on) (NP (NP (NNP Friday) (NNP March)) (PRN (-LRB- -LRB-) (NP (NP (NNS fivedays)) (PP (IN after) (NP (VBG increasing) (NN dose)))) (-RRB- -RRB-))))))))) (. .)))","(X (X Her) (X neurontin) (X dose) (X was) (X also) (X increased) (X to) (X 600mgthree) (X times) (X daily.ADDITIONAL) (X COMMENTS) (X :) (X 1) (X -RRB-) (X Please) (X draw) (X dilantin) (X level) (X on) (X Friday) (X 4/3/07) (X and) (X send) (X results) (X tooutpatient) (X primary) (X care) (X physician) (X and) (X outpatient) (X neurologist) (X .2) (X -RRB-) (X Please) (X help) (X pt) (X with) (X medication) (X teaching) (X ,) (X especially) (X as) (X regardsanti-epileptics) (X -LRB-) (X dilantin) (X ,) (X neurontin) (X -RRB-) (X in) (X order) (X to) (X improve) (X outptcompliance) (X and) (X reduce) (X frequency) (X of) (X seizures.DISCHARGE) (X CONDITION) (X :) (X StableTO) (X DO/PLAN) (X :1) (X -RRB-) (X Please) (X follow) (X up) (X dilantin) (X level) (X to) (X be) (X drawn) (X by) (X VNA) (X on) (X Friday) (X 10/21/07) (X .2) (X -RRB-) (X Consider) (X PFTs/sleep) (X study) (X as) (X outpt.No) (X dictated) (X summaryENTERED) (X BY) (X :) (X ANCELL) (X ,) (X JR) (X ,) (X GIUSEPPE) (X W.) (X ,) (X M.D.) (X -LRB-) (X ES28) (X -RRB-) (X 3/26/07) (X @) (X 04) (X ******) (X END) (X OF) (X DISCHARGE) (X ORDERS) (X ******))"]}
